CCNE2, an S phase cyclin is frequently overexpressed in breast cancer [105] with previous studies reported the overexpression of Cyclin E including CCNE2 in IBC, with correlation of poor prognosis in IBC patients [106]. The gene discussed is CCNE1; the disease is inflammatory breast carcinoma.